Credlin Keneally not having regular guests. Instead, Credlin and Keneally discuss five political issues from the week between themselves. Credlin Keneally Credlin Keneally (originally announced as Credlin & Keneally) is an Australian television news and commentary program broadcast weekly on Sky News Australia. The program is co-hosted by Peta Credlin and Kristina Keneally and features long-form discussion of political issues between the presenters. The format marks the first time a program on Sky News has been hosted by two women. The program is the first permanent hosting position for Credlin, who joined Sky News as a contributor in May 2016. It is
Schindler disease of the disease is mostly palliative. However, Type II Schindler disease, with its late onset of symptoms, is not characterized by neurological degeneration. There is no known cure for Schindler disease, but bone marrow transplants have been trialed, as they have been successful in curing other glycoprotein disorders. Schindler disease was named after Detlev Schindler (1946- ) M.D., the first author of a 1988 paper detailing the disease. It also named after the Japanese Biochemist and Physician, Hiro Kanzaki (1949- ), who further studied it and released papers detailing the disease in 2006. Schindler disease Schindler disease, also known as